bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 31, 2023
Abstract
Objective
Pancreatic
islets
are
nutrient
sensors
that
regulate
organismal
blood
glucose
homeostasis.
Glucagon
release
from
the
pancreatic
α-cell
is
important
under
fasted,
fed,
and
hypoglycemic
conditions,
yet
metabolic
regulation
of
α-cells
remains
poorly
understood.
Here,
we
identified
a
previously
unexplored
role
for
physiological
levels
leucine,
which
classically
regarded
as
β-cell
fuel,
in
intrinsic
glucagon
release.
Methods
GcgCre
ERT
:CAMPER
:GCaMP6s
mice
were
generated
to
perform
dynamic,
high-throughput
functional
measurements
cAMP
Ca
2+
within
intact
islet.
Islet
perifusion
assays
used
simultaneous,
time-resolved
insulin
mouse
human
islets.
The
effects
leucine
compared
with
mitochondrial
fuels
2-aminobicyclo(2,2,1)heptane-2-carboxylic
acid
(BCH,
non-metabolized
analog
activates
glutamate
dehydrogenase),
α-ketoisocaproate
(KIC,
metabolite),
methyl-succinate
(complex
II
fuel).
CYN154806
(Sstr2
antagonist),
diazoxide
(K
ATP
activator,
prevents
-dependent
exocytosis
α,
β,
δ-cells),
dispersed
inhibit
islet
paracrine
signaling
identify
effects.
Results
Mimicking
effect
glucose,
strongly
suppressed
amino
acid-stimulated
secretion.
Mechanistically,
dose-dependently
reduced
at
concentrations,
an
IC
50
57,
440,
1162
μM
2,
6,
10
mM
without
affecting
.
Leucine
also
treated
Sstr2
antagonist
or
diazoxide,
well
α-cells,
indicating
effect.
was
matched
by
KIC
dehydrogenase
activator
BCH,
but
not
methyl-succinate,
dependence
on
anaplerosis.
Glucose,
stimulates
anaplerosis
via
pyruvate
carboxylase,
had
same
suppressive
lower
potency.
Similarly
islets,
secretion
conditions.
Conclusions
These
findings
highlight
functions
primarily
through
dependent
dehydrogenase,
addition
well-established
β/δ-cell
signaling.
Our
results
suggest
anaplerosis-cataplerosis
facilitates
glucagonostatic
both
cooperatively
suppress
tone
reducing
cAMP.
Graphical
Highlights
inhibits
suppresses
direct
Anaplerosis
sufficient
more
potently
than
Cell Metabolism,
Journal Year:
2024,
Volume and Issue:
36(9), P. 1963 - 1978
Published: Aug. 23, 2024
SummaryOxidative
phosphorylation
(OXPHOS)
occurs
through
and
across
the
inner
mitochondrial
membrane
(IMM).
Mitochondrial
membranes
contain
a
distinct
lipid
composition,
aided
by
biosynthetic
machinery
localized
in
IMM
class-specific
transporters
that
limit
traffic
out
of
mitochondria.
This
unique
composition
appears
to
be
essential
for
functions
mitochondria,
particularly
OXPHOS,
its
effects
on
direct
lipid-to-protein
interactions,
properties,
cristae
ultrastructure.
review
highlights
biological
significance
lipids,
with
particular
spotlight
role
lipids
bioenergetics.
We
describe
pathways
biosynthesis
provide
evidence
their
roles
physiology,
implications
human
disease,
mechanisms
which
they
regulate
Diabetes,
Journal Year:
2024,
Volume and Issue:
73(6), P. 849 - 855
Published: April 19, 2024
The
canonical
model
of
glucose-induced
increase
in
insulin
secretion
involves
the
metabolism
glucose
via
glycolysis
and
citrate
cycle,
resulting
increased
ATP
synthesis
by
respiratory
chain
closure
ATP-sensitive
K+
(KATP)
channels.
plasma
membrane
depolarization,
followed
Ca2+
influx
through
L-type
channels,
then
induces
granule
fusion.
Merrins
colleagues
have
recently
proposed
an
alternative
whereby
KATP
channels
are
controlled
pyruvate
kinase,
using
glycolytic
mitochondrial
phosphoenolpyruvate
(PEP)
to
generate
microdomains
high
ATP/ADP
immediately
adjacent
This
presents
several
challenges.
First,
how
mitochondrially
generated
PEP,
but
not
produced
abundantly
F1F0-ATP
synthase,
can
gain
access
is
unclear.
Second,
fluctuations
imaged
beneath
closely
resemble
those
bulk
cytosol.
Third,
ADP
privation
at
glucose,
suggested
drive
alternating,
phased-locked
generation
mitochondria
or
has
yet
be
directly
demonstrated.
Finally,
approaches
used
explore
these
questions
may
complicated
off-target
effects.
We
suggest
instead
that
changes,
well
known
affect
both
consumption,
likely
cytosolic
oscillations
turn
regulate
potential.
Thus,
it
remains
demonstrated
a
new
required
replace
existing,
bioenergetics–based
model.
Frontiers in Molecular Biosciences,
Journal Year:
2024,
Volume and Issue:
11
Published: Feb. 9, 2024
In
Type
1
and
2
diabetes,
pancreatic
β-cell
survival
function
are
impaired.
Additional
etiologies
of
diabetes
include
dysfunction
in
insulin-sensing
hepatic,
muscle,
adipose
tissues
as
well
immune
cells.
An
important
determinant
metabolic
health
across
these
various
is
mitochondria
structure.
This
review
focuses
on
the
role
pathogenesis,
with
a
specific
emphasis
β-cells.
These
dynamic
organelles
obligate
for
survival,
function,
replication,
insulin
production,
control
over
release.
Therefore,
it
not
surprising
that
severely
defective
diabetic
contexts.
Mitochondrial
poses
challenges
to
assess
cause-effect
studies,
prompting
us
assemble
deliberate
evidence
cause
or
consequence
diabetes.
Understanding
precise
molecular
mechanisms
underlying
mitochondrial
identifying
therapeutic
strategies
restore
homeostasis
enhance
active
expanding
areas
research.
summary,
this
examines
multidimensional
focusing
β-cells
highlighting
significance
metabolism,
bioenergetics,
calcium,
dynamics,
mitophagy
pathophysiology
We
describe
effects
diabetes-related
gluco/lipotoxic,
oxidative
inflammation
stress
mitochondria,
played
by
pathologic
outcomes
paradigms.
By
examining
aspects,
we
provide
updated
insights
highlight
where
further
research
required
deeper
understanding
Acta Physiologica,
Journal Year:
2024,
Volume and Issue:
240(6)
Published: April 24, 2024
Abstract
Pancreatic
β
cells
play
an
essential
role
in
the
control
of
systemic
glucose
homeostasis
as
they
sense
blood
levels
and
respond
by
secreting
insulin.
Upon
stimulating
uptake
insulin‐sensitive
tissues
post‐prandially,
this
anabolic
hormone
restores
to
pre‐prandial
levels.
Maintaining
physiological
thus
relies
on
proper
β‐cell
function.
To
fulfill
highly
specialized
nutrient
sensor
role,
have
evolved
a
unique
genetic
program
that
shapes
its
distinct
cellular
metabolism.
In
review,
metabolic
features
will
be
outlined,
including
their
alterations
type
2
diabetes
(T2D).
selectively
express
set
genes
cell
type‐specific
manner;
for
instance,
activating
hexokinase
IV
enzyme
or
Glucokinase
(
GCK
),
whereas
other
are
“disallowed”,
lactate
dehydrogenase
A
LDHA
)
monocarboxylate
transporter
1
MCT1
).
This
selective
gene
equips
with
apparatus
ensure
metabolism
is
coupled
appropriate
insulin
secretion,
thereby
avoiding
hyperglycemia,
well
life‐threatening
hypoglycemia.
Unlike
most
types,
exhibit
bioenergetic
features,
supply‐driven
rather
than
demand‐driven
high
basal
mitochondrial
proton
leak
respiration.
The
understanding
these
genetically
programmed
lead
dysfunction
crucial
comprehensive
T2D
pathophysiology
development
innovative
therapeutic
approaches
patients.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
175, P. 116755 - 116755
Published: May 20, 2024
With
the
increasing
prevalence
of
type
2
diabetes
mellitus
(T2DM),
it
has
become
critical
to
identify
effective
treatment
strategies.
In
recent
years,
novel
oral
hypoglycaemic
drug
Imeglimin
attracted
much
attention
in
field
treatment.
The
mechanisms
its
therapeutic
action
are
complex
and
not
yet
fully
understood
by
current
research.
Current
evidence
suggests
that
pancreatic
β-cells,
liver,
skeletal
muscle
main
organs
which
lowers
blood
glucose
levels
acts
mainly
targeting
mitochondrial
function,
thereby
inhibiting
hepatic
gluconeogenesis,
enhancing
insulin
sensitivity,
promoting
β-cell
regulating
energy
metabolism.
There
is
growing
also
a
potentially
volatile
role
diabetic
complications,
including
metabolic
cardiomyopathy,
vasculopathy,
neuroinflammation.
According
available
clinical
studies,
efficacy
safety
profile
more
evident
than
other
agents,
synergistic
effects
when
combined
with
antidiabetic
drugs,
potential
T2DM-related
complications.
This
review
aims
shed
light
on
latest
research
progress
T2DM
Imeglimin,
providing
clinicians
researchers
insights
into
as
viable
option
for
T2DM.
Cells,
Journal Year:
2024,
Volume and Issue:
13(21), P. 1783 - 1783
Published: Oct. 28, 2024
Islet
transplantation
is
a
promising
approach
for
treating
patients
with
unstable
T1DM.
However,
it
confronted
numerous
obstacles
throughout
the
various
stages
of
procedure.
Significant
progress
has
been
made
over
last
25
years
in
understanding
mechanisms
behind
loss
functional
islet
mass
and
developing
protective
strategies.
Nevertheless,
at
present,
two
to
three
pancreases
are
still
needed
treat
single
patient,
which
limits
maximal
number
who
can
benefit
from
transplantation.
Thus,
this
publication
provides
an
overview
recent
scientific
findings
on
issues
affecting
Specifically,
we
will
focus
involved
strategies
developed
alleviate
these
problems
isolation
stage
post-transplantation
phase.
Finally,
hope
that
review
highlight
new
avenues
action,
enabling
us
propose
pancreatic
maximum
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 30, 2024
Abstract
Glucagon-like
peptide-1
receptor
(GLP-1R)
agonists
(GLP-1RAs)
ameliorate
mitochondrial
health
by
increasing
its
turnover
and
improving
quality
control.
While
the
GLP-1R
is
well
known
to
stimulate
cAMP
production
leading
activation
of
Protein
Kinase
A
(PKA)
Exchange
Activated
cyclic
AMP
2
(Epac2)
signalling,
there
a
lack
understanding
molecular
mechanisms
linking
GLP-1RA-induced
signalling
with
remodelling
improved
function.
Here
we
present
dataset
that
demonstrates
that,
following
GLP-1RA
stimulation
in
pancreatic
β-cells,
interacts
endoplasmic
reticulum
(ER)
membrane
contact
site
(MCS)
organising
factor
VAP-B
from
an
endocytic
location
engage
SPHKAP,
A-kinase
anchoring
protein
(AKAP)
associated
type
diabetes
(T2D)
adiposity
genome-wide
association
studies
(GWAS),
trigger
pool
mitochondrially
localised
PKA
phosphorylates
cristae
organizing
system
(MICOS)
complex
component
MIC19,
enabling
optimal
β-cell